Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases
Open Access
- 14 June 2025
- journal article
- research article
- Published by Springer Nature in Advances in Rheumatology
- Vol. 65 (1) , 1-9
Abstract
Background: Myocardial fibrosis is an important adverse prognostic marker, however; determinants of myocardial fibrosis in immune-mediated inflammatory diseases (IMIDs) remain poorly defined. We aimed to identify determinants of myocardial fibrosis in patients with IMIDs, as measured by cardiovascular magnetic resonance (CMR) extracellular volume (ECV). Methods: Cross-sectional study of 116 patients with IMIDs undergoing clinical CMR at Manchester University NHS Foundation Trust. IMIDs included rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (SSc), ankylosing spondylitis, psoriatic arthritis and vasculitis. CMR included pre- and post-contrast T1 mapping to measure myocardial ECV, with same day blood sampling. Determinants of ECV were investigated with univariable and multivariable linear regression. Results: ECV varied significantly according to IMID diagnosis (ANOVA F statistic 2.80, P = 0.015); ECV was higher in patients with SSc compared to other IMIDs. Major determinants of ECV as a continuous variable were SSc, smoking and body mass index (BMI); regression coefficients 3.33 (95% confidence interval 0.82–5.84), 3.08 (0.73–5.43), and − 0.19 (-0.29 – -0.09) respectively, P < 0.01 (SSc, smoking and lower BMI were associated with increased ECV). Approximately a quarter of the variability in ECV could be explained by these predictors (optimism adjusted R 2 0.265). Conclusion: SSc is associated with a higher burden of myocardial fibrosis compared to other IMIDs. In patients with IMIDs, independent determinants of myocardial fibrosis were presence of SSc, smoking and BMI. Importantly, participants underwent CMR for clinical indications and may not be representative of IMID populations in the community.Keywords
Funding Information
- National Institute for Health and Care Research (CS-2015-15-003)
- Guerbet
- British Heart Foundation (AA/18/4/34221)
- Manchester Biomedical Research Centre (NIHR 203308)
This publication has 47 references indexed in Scilit:
- Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosisClinical Radiology, 2021
- Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitisThe International Journal of Cardiovascular Imaging, 2020
- Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trialRheumatology International, 2020
- Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA)JACC, 2017
- Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MIJACC: Cardiovascular Imaging, 2017
- Magnetic Resonance Imaging–Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N‐Terminal Pro–Brain Natriuretic Peptide LevelsArthritis Care & Research, 2017
- Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch blockInternational Journal of Cardiology, 2014
- Cardiac Tissue Characterization and the Diagnostic Value of Cardiovascular Magnetic Resonance in Systemic Connective Tissue DiseasesArthritis Care & Research, 2013
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Multiple Imputation for Nonresponse in Surveys1987